Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

NCT06821126 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

238

Enrollment

OTHER_GOV

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: LVT-001
BIOLOGICAL: Cormirnaty

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]